Search

everythinglearnresearchcommunity

for

Search:↓

Higher antigliadin antibodies are linked to more severe alopecia areata, suggesting screening for celiac disease in these patients.

New cytokine-targeted therapies show promise for treating alopecia areata.

New treatments for severe alopecia areata show promise but lack standard approval.

Connubial contact dermatitis is often missed, making treatment harder.

Patients with autoimmune blistering diseases experience a reduced quality of life, with the need for better measurement tools, especially for those with mucous membrane pemphigoid.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

Hidradenitis suppurativa is a chronic skin condition more common in women, linked to genetics and lifestyle factors, and associated with various other health issues.

Some natural remedies may help with hair regrowth, but more research is needed to confirm their effectiveness and safety.

Adalimumab is the most effective treatment for severe hidradenitis suppurativa, but more research is needed to improve treatment options.

The conference presented findings on how vitamin D levels, genetic factors, and lifestyle choices like smoking and yoga affect various health conditions and diseases.

Melanocytes produce melanin; their defects cause vitiligo and hair graying, with treatments available for vitiligo.

Diagnosing alopecia areata is challenging and requires careful examination and various tests to distinguish it from other hair loss types.

The document concludes that dermatology training and grading scales need to better represent dark-skinned individuals to improve diagnosis and assessment of skin conditions.

Any drug can cause skin reactions, but antibiotics, NSAIDs, and psychotropic drugs are more common, with some reactions being life-threatening.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

JAK inhibitors show promise in treating skin conditions like eczema, hair loss, and vitiligo but need more safety research.

Children with alopecia areata often face more stress and depression, especially related to separation, which can affect their condition.

Low vitamin D levels may worsen or cause alopecia areata.

Baricitinib 4 mg should be used for at least 1 year to see significant hair regrowth in severe alopecia areata.

Many medications may be linked to cognitive disorders, but most lack warnings on labels.

Cancer survivors need better skin care to improve their quality of life.

Skin conditions can signal diabetes and insulin resistance.

Autologous cell-based therapies, especially SVF, effectively and safely improve atrophic acne scars.

Experts created guidelines to better diagnose and treat uncommon fungal skin infections.

Early recognition of skin issues in immunocompromised patients is crucial for better outcomes.

Dermatologists are key in detecting and managing OCD and BFRBs by working with psychiatrists.

JAK inhibitors and combination therapies show promise for treating severe alopecia areata.

Alopecia areata in Taiwan has a high disease burden and needs better research and diagnostic criteria.

Scalp cooling is cost-effective for reducing hair loss from chemotherapy and should be covered by insurance.

Tofacitinib is more effective than traditional treatments for severe alopecia areata in children.